Patrick Hilden

2.2k total citations
76 papers, 1.1k citations indexed

About

Patrick Hilden is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Patrick Hilden has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 20 papers in Oncology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Patrick Hilden's work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (17 papers). Patrick Hilden is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (17 papers). Patrick Hilden collaborates with scholars based in United States, Spain and Canada. Patrick Hilden's co-authors include Sergio Giralt, Miguel‐Angel Perales, Sean M. Devlin, Craig S. Sauter, Hugo Castro‐Malaspina, Ann A. Jakubowski, Esperanza B. Papadopoulos, Molly Maloy, Åse Ballangrud and Philip H. Gutin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Patrick Hilden

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Hilden United States 18 341 334 303 223 179 76 1.1k
Sudipto Mukherjee United States 17 319 0.9× 573 1.7× 149 0.5× 283 1.3× 103 0.6× 139 1.2k
Edward G. Weir United States 17 267 0.8× 313 0.9× 109 0.4× 149 0.7× 102 0.6× 25 914
Jeffrey Margolis United States 18 307 0.9× 524 1.6× 227 0.7× 154 0.7× 62 0.3× 35 1.1k
Pamela Crilley United States 20 622 1.8× 797 2.4× 373 1.2× 153 0.7× 186 1.0× 69 1.8k
Alison M. Friedmann United States 21 237 0.7× 210 0.6× 520 1.7× 172 0.8× 85 0.5× 56 1.3k
Satish Shanbhag United States 14 278 0.8× 337 1.0× 103 0.3× 190 0.9× 92 0.5× 37 931
Sevgi Kalayoğlu Beşışık Türkiye 16 340 1.0× 255 0.8× 66 0.2× 284 1.3× 104 0.6× 100 915
Sacha Satram‐Hoang United States 16 537 1.6× 189 0.6× 117 0.4× 152 0.7× 48 0.3× 48 1.0k
Axel Matzdorff Germany 20 230 0.7× 747 2.2× 149 0.5× 249 1.1× 41 0.2× 76 1.3k
Joe C. Files United States 19 164 0.5× 282 0.8× 158 0.5× 309 1.4× 88 0.5× 33 1.2k

Countries citing papers authored by Patrick Hilden

Since Specialization
Citations

This map shows the geographic impact of Patrick Hilden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hilden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hilden more than expected).

Fields of papers citing papers by Patrick Hilden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Hilden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hilden. The network helps show where Patrick Hilden may publish in the future.

Co-authorship network of co-authors of Patrick Hilden

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Hilden. A scholar is included among the top collaborators of Patrick Hilden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Hilden. Patrick Hilden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Kevin, et al.. (2023). Outcomes of ventriculoperitoneal shunt placement with or without laparoscopic assistance: An analysis of the national inpatient sample. World Neurosurgery X. 21. 100266–100266. 1 indexed citations
2.
Koshenkov, Vadim P., Alissa Greenbaum, Catherine H. Davis, et al.. (2023). Factors Associated With Upstaging of Melanoma Thickness on Final Excision. Journal of Surgical Research. 289. 253–260. 1 indexed citations
3.
Patel, Smit, et al.. (2022). The weekend effect on mechanical thrombectomy. SHILAP Revista de lepidopterología. 8(3). 137–145. 10 indexed citations
4.
Bamboat, Zubin M., et al.. (2021). Impact of postoperative complications on long‐term survival after esophagectomy in older adults: A SEER‐Medicare analysis. Journal of Surgical Oncology. 124(5). 751–766. 5 indexed citations
5.
Morris, Michael J., José Maurício Mota, Patrick Hilden, et al.. (2021). Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503). European Urology Oncology. 4(4). 543–552. 11 indexed citations
6.
Maitland, Michael L., Julia Wilkerson, Binsheng Zhao, et al.. (2020). Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation. Clinical Cancer Research. 26(24). 6464–6474. 26 indexed citations
7.
Hilden, Patrick, et al.. (2020). Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study. International Journal of Antimicrobial Agents. 57(2). 106265–106265. 6 indexed citations
8.
Friedman, Danielle Novetsky, Chaya S. Moskowitz, Patrick Hilden, et al.. (2019). Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus: A Report from the Childhood Cancer Survivor Study. JNCI Journal of the National Cancer Institute. 112(5). 525–532. 31 indexed citations
9.
Scordo, Michael, Valkal Bhatt, Patrick Hilden, et al.. (2019). Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1526–1535. 17 indexed citations
10.
Rondon-Clavo, Carlos, Michael Scordo, Patrick Hilden, et al.. (2018). Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(12). 2517–2522. 14 indexed citations
11.
Derenzini, Enrico, Patrizia Mondello, Tatiana Erazo, et al.. (2018). BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors. Cell Reports. 24(8). 2155–2166. 27 indexed citations
12.
Pandit‐Taskar, Neeta, Pat Zanzonico, Patrick Hilden, et al.. (2017). Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy. Clinical Nuclear Medicine. 42(10). 741–748. 15 indexed citations
13.
Spitzer, Barbara, Ann A. Jakubowski, Esperanza B. Papadopoulos, et al.. (2017). A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of Blood and Marrow Transplantation. 23(12). 2088–2095. 8 indexed citations
14.
Jakubowski, Ann A., Molly Maloy, Patrick Hilden, et al.. (2017). T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 23(10). 1685–1694. 11 indexed citations
15.
Friedman, Danielle Novetsky, Patrick Hilden, Chaya S. Moskowitz, et al.. (2016). Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis. Biology of Blood and Marrow Transplantation. 23(3). 475–482. 29 indexed citations
16.
Hobbs, Gabriela, Patrick Hilden, Daniela Ponce, et al.. (2016). A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation. Bone Marrow Transplantation. 51(7). 1010–1012. 10 indexed citations
17.
Pietanza, M. Catherine, Matthew D. Hellmann, John J. Fiore, et al.. (2016). Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of Thoracic Oncology. 11(6). 890–899. 2 indexed citations
18.
Peterson, Tim, Andrew Lin, Patrick Hilden, et al.. (2015). Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL). Blood. 126(23). 1290–1290.
19.
Hobbs, Gabriela, Amir Hamdi, Patrick Hilden, et al.. (2015). Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone Marrow Transplantation. 50(4). 493–498. 28 indexed citations
20.
Lendvai, Nikoletta, Patrick Hilden, Sean M. Devlin, et al.. (2014). A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma. Blood. 124(6). 899–906. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026